← FDA DRUG APPROVALS

FDA ANDA · ANDA075585

CROMOLYN SODIUM

Sponsor: BAUSCH

APPLICATION
ANDA075585
TYPE
ANDA
ORIGINAL APPROVAL
2000-12-21
LATEST ACTION
2002-10-09
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CROMOLYN SODIUMDiscontinued
CROMOLYN SODIUM 10MG/ML · SOLUTION · INHALATION

Approval history

2002-10-09Manufacturing (CMC) · Supplement 3AP
2001-11-27Manufacturing (CMC) · Supplement 2AP
2000-12-21OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →